Zelefsky, Michael J <br/><br/>
Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.  [electronic resource] 

 -  European urology  Dec 2011 
 - 1133-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2011.08.029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androgen Antagonists--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Chemotherapy, Adjuvant<br/>Disease-Free Survival<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>New York City<br/>Nomograms<br/>Proportional Hazards Models<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--immunology<br/>Radiotherapy Dosage<br/>Radiotherapy, Conformal--adverse effects<br/>Radiotherapy, Intensity-Modulated--adverse effects<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome